3-Week inhalation exposure to cigarette smoke and/or lipopolysaccharide in AKR/J mice

Inhalation Toxicology

Volumn 19, Issue 1, 2007, Pages 23-35

  Lee, K Monica ^a   Renne, Roger A ^a   Harbo, Sam J ^a   Clark, Mark L ^a   Johnson, Renee E ^a   Gideon, Kathy M ^a  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLOGY; ENVIRONMENTAL EXPOSURE; IMMUNE RESPONSE; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AEROSOLS; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; CARBOXYHEMOGLOBIN; COTININE; CYTOKINES; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; INHALATION EXPOSURE; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED AKR; NEUTROPHILS; NICOTINE; PARTICLE SIZE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RESPIRATORY SYSTEM; SMOKE; TIME FACTORS; TOBACCO;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; RODENTIA;

EID: 33845250468     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370600985784     Document Type: Article

References (40)

1. Barnes, P. J., Chowdhury, B., Kharitonov, S.A., Magnussen, H., Page, C.P., Postma, D., and Saetta, M. 2006. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 174:6-14.
2. Belperio, J. A., Dy, M., Murray, L., Burdick, M. D., Xue, Y. Y., Strieter, R. M., and Keane, M. P. 2004. The role of the TH2 CC chemokine ligand CCL17 in pulmonary fibrosis. J. Immunol. 173:4692-4698.
3. Brusselle, G. G., Bracke, K. R., Maes, T., D'hulst, A. I., Moerloose, K. B., Joos, G. F., and Pauwels, R. A. 2005. Murine models of COPD. Pulmon. Pharmacol. Ther. 19:155-165.
4. Cavagna, G., Foa, V., and Vigliani, E. C. 1969. Effects inmanand rabbits of inhalation of cotton dust or extracts and purified endotoxins. Br. J. Ind. Med. 26:314-321.
5. Chung, K. F. 2001. Cytokines in chronic obstructive pulmonary disease. Eur. Respir. J. Suppl., 34:50s-59s.
6. Churg, A., Dai, J., Tai, H., Xie, C., and Wright, J. L. 2002. Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am. J. Respir. Crit. Care Med. 166:849-854.
7. Cosio, M. G., and Majo, J. 2002. Inflammation of the airways and lung parenchyma in COPD: Role of T cells. Chest 121:160S-165S.
8. Cosio Piqueras, M. G., and Cosio, M. G. 2001. Disease of the airways in chronic obstructive pulmonary disease. Eur. Respir. J. Suppl. 34:41s-49s.
9. Feghali, C. A., and Wright, T. M. 1997. Cytokines in acute and chronic inflammation. Front Biosci. 2:d12-26.
10. Groneberg, D. A., and Chung, K. F. 2004. Models of chronic obstructive pulmonary disease. Respir. Res. 5:18.
11. Guerassimov, A., Hoshino, Y., Takubo, Y., Turcotte, A., Yamamoto, M., Ghezzo, H., Triantafillopoulos, A., Whittaker, K., Hoidal, J. R., and Cosio, M. G. 2004. The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am. J. Respir. Crit. Care Med. 170:974-980.
12. Hasday, J. D., Bascom, R., Costa, J. J., Fitzgerald, T., and Dubin, W., 1999. Bacterial endotoxin is an active component of cigarette smoke. Chest 115:829-835.
13. Higuchi, M. A., Sagartz, J., Shreve, W. K., and Ayres, P. H. 2004. Comparative subchronic inhalation study of smoke from the 1R4F and 2R4F reference cigarettes. Inhal. Toxicol. 16:1-20.
14. Kopydlowski, K. M., Salkowski, C. A., Cody, M. J., van Rooijen, N., Major, J., Hamilton, T. A., and Vogel, S. N. 1999. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J. Immunol. 163:1537-1544
15. Lee, K. M., Renne, R. A., Harbo, S. J., Blessing, J. C., Clark, M. L., Johnson, R. E., and Gideon, K. M. 2006. Pulmonary responses of AKR/J mice exposed to LPS and/or cigarette smoke for up to 3-week via nose-only inhalation. Toxicologist 60:1661.
16. March, T. H., Barr, E. B., Finch, G. L., Hahn, F. F., Hobbs, C. H., Ménache, M. G., and Nikula, K. J. 1999. Cigarette smoke exposure produces more evidence of emphysema in B6C3F1 than in F344 rats. Toxicol. Sci. 51:289-299.
17. March, T. H., Green, F. H., Hahn, F. F., and Nikula, K. J. 2000. Animal models of emphysema and their relevance to studies of particle-induced disease. Inhal. Toxicol. 12:155-187.
18. March, T. H., Wilder, J. A., Esparza, D. C., Cossey, P. Y., Blair, L. F., Herrera, L. K., McDonald, J. D., Campen, M. J., Mauderly, J. L., and Seagrave, J. C. 2006. Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice. Toxicol. Sci. 92:545-559.
19. Martin, T. R. 2000. Recognition of bacterial endotoxin in the lungs. Am. J. Respir. Cell Mol. Biol. 23:128-132.
20. Meng, Q. R., Brys, A. M., Jones, R., Gideon, K. M., Harbo, S. J., Renne, R. A., and Lee, K. M. 2006. Gene expression profiling in lung tissues from mice exposed to cigarette smoke, lipopolysaccharide, or smoke plus lipopolysaccharide by inhalation. Inhal. Toxicol. 18:555-568.
21. Michel, O., Duchateau, J., and Sergysels, R. 1989. Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J. Appl. Physiol. 66:1059-1064.
22. Michel, O., Duchateau, J., Plat, G., Cantinieaux, B., Hotimsky, A., Gerain, J., and Sergysels, R. 1995. Blood inflammatory response to inhaled endotoxin in normal subjects. Clin. Exp. Allergy 25:73-79.
23. Nevalainen, M., Raulo, S. M., Brazil, T. J., Pirie, R. S., Sorsa, T., McGorium, B. C., and Maisi, P. 2002. Inhalation of organic dusts and lipopolysaccharide increases gelatinolytic matrix metalloproteinases (MMPs) in the lungs of heaves horses. Equine. Vet. J. 34:150-155.
24. Obot, C. J., Fuciarelli, A. F., Lee, K. M., and McKinney, W. J. 2003. Comparative analysis of cigarette smoke (CS)-induced biomarkers in bronchoalveolar lavage (BAL) fluid of two strains of mice. Toxicologist 72:1428.
25. Obot, C., Lee, K., Fuciarelli, A., Renne, R., and McKinney, W. 2004. Characterization of mainstream cigarette smoke-induced biomarker responses in ICR and C57Bl/6 mice. Inhal. Toxicol. 16:701-719.
26. Pauwels, R. A., Buist, A. S., Calverley, P. M., Jenkins, C. R., and Hurd, S. S. 2001. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Res. Crit. Care Med. 163:1256-1276.
27. Rylander, R. 1981. Bacterial toxins and etiology of byssinosis. Chest 79(4 Suppl):34S-38S.
28. Sethi, S. 2004. Bacteria in exacerbations of chronic obstructive pulmonary disease: Phenomenon or epiphenomenon? Proc. Am. Thorac. Soc. 1:109-114.
29. Sjöstrand, M., and Rylander, R. 1984. Lung cell reactions in guinea pigs exposed to tobacco smoke and silica dust or bacterial lipopolysaccharide. Toxicology 29:271-280.
30. Smid, T., Heederik, D., Houba, R., and Quanjer, P. H. 1994. Dust-and endotoxin-related acute lung function changes and work-related symptoms in workers in the animal feed industry. Am. J. Ind. Med. 25:877-888.
31. Spond, J., Billah, M. M., Chapman, R. W., Egan, R. W., Hey, J. A., House, A., Kreutner, W., and Minnicozzi, M. 2004. The role of neutrophils in LPS-induced changes in pulmonary function in conscious rats. Pulmon. Pharmacol. Ther. 17:133-140.
32. Springer, D. L., Johnson, R. E., Strittmatter, E. F., Moore, R. J., Pounds, J. G., Lee, K. M., and Miller, J. H. 2006. Global proteomic changes in mouse lung after inhalation exposure to lipopolysaccharide (LPS) and/or cigarette smoke. Toxicologist 60:183.
33. Springer, D. L., Johnson, R. E., Daly, D. S., Moore, R. J., Bandyopadhyay, S., Jin, S., Lee, K. M., Waters, K. M., and Miller, J. H., Protein profile changes in mouse lung after inhalation exposure to lipopolysaccharide (LPS) and/or cigarette smoke by high-throughput quantitative mass spectrometry. Proteomics, in preparation.
34. Toward, T. J., and Broadley, K. J. 2002. Goblet cell hyperplasia, airway function, and leukocyte infiltration after chronic lipopolysaccharide exposure in conscious guinea pigs: Effects of rolipram and dexamethasone. J. Pharmacol. Exp. Ther. 302:814-821.
35. Underwood, D. C., Osborn, R. R., Bochnowicz, S., Webb, E. F., Rieman, D. J., Lee, J. C., Romanic, A. M., Adams, J. L., Hay, D. W. P., and Griswold, D. E. 2000. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am. J. Physiol. Lung Cell Mol. Physiol. 279:L895-L902.
36. van der Vaart, H., Postma, D. S., Timens, W., Hylkema, M. N., Willemse, B. W., Boezen, H. M., Vonk, J. M., de Reus, D. M., Kauffman, H. F., and ten Hacken, N. H. 2005. Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respir. Res. 6:22
37. Vernooy, J. H., Dentener, M. A., van Suylen, R. J., Buurman, W. A., and Wouters, E. F. 2001. Intratracheal instillation of lipopolysaccharide in mice induces apoptosis in bronchial epithelial cells: No role for tumor necrosis factor-alpha and infiltrating neutrophils. Am. J. Respir. Cell Mol. Biol. 24:569-576.
38. Vernooy, J. H., Denterner, M. A., Van Suylen, R. J., Buurman, W. A., and Wouters, E. F. 2002. Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am. J. Respir. Cell Mol. Biol. 26:152-159.
39. Vogelzang, P. F., Van Der Gulden, J. W., Folgering, H., Kolk, J. J., Heederik, D., Preller, L., Tielen, M. J., and Van Schayck, C. P. 1998. Endotoxin exposure as a major determinant of lung function decline in pig farmers Am. J. Respir. Crit. Care Med. 157:15-18.
40. Willemse, B. W., ten Hacken, N. T., Rutgers, B., Postma, D. S., and Timens, W. 2005. Association of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokers. Respir. Res. 6:38.